Identification of Genes Associated with Lung Adenocarcinoma Prognosis
-
Published:2019-07-24
Issue:4
Volume:22
Page:220-224
-
ISSN:1386-2073
-
Container-title:Combinatorial Chemistry & High Throughput Screening
-
language:en
-
Short-container-title:CCHTS
Author:
He Zhe-Hao1, Lv Wang1, Wang Lu-Ming1, Wang Yi-Qing1, Hu Jian1
Affiliation:
1. Department of Thoracic Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China
Abstract
Objective:Lung cancer is the most prevalent cancer in the world, and lung adenocarcinoma is the most common lung cancer subtype. Identification and determination of relevant prognostic markers are the key steps to personalized cancer management.Methods:We collected the gene expression profiles from 265 tumor tissues of stage I patients from The Cancer Genome Atlas (TCGA) databases. Using Cox regression model, we evaluated the association between gene expression and the overall survival time of patients adjusting for gender and age at initial pathologic diagnosis.Results:Age at initial pathologic diagnosis was identified to be associated with the survival, while gender was not. We identified that 15 genes were significantly associated with overall survival time of patients (FDR < 0.1). The 15-mRNA signature- based risk score was helpful to distinguish patients of high-risk group from patients of low-risk group.Conclusion:Our findings reveal novel genes associated with lung adenocarcinoma survival and extend our understanding of how gene expression contributes to lung adenocarcinoma survival. These results are helpful for the prediction of the prognosis and personalized cancer management.
Funder
Foundation of Zhejiang Provincial Traditional Chinese Medicine Scientific Research Plan Key Discipline of Zhejiang Province Traditional Chinese Medicine National Key Research and Development Program of China
Publisher
Bentham Science Publishers Ltd.
Subject
Organic Chemistry,Computer Science Applications,Drug Discovery,General Medicine
Reference28 articles.
1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Govindan R, Grannis FW, Grant SC, Horn L, Jahan TM, Komaki R, Kong FM, Kris MG, Krug LM, Lackner RP, Lennes IT, Loo BW, Martins R, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Shapiro TA, Swanson SJ, Tauer K, Wood DE, Yang SC, Gregory K, Hughes M. J Natl Compr Canc Netw, National comprehensive cancer network. Non-small cell lung cancer, version 2.2013.,, 2013, 11,, 645-653,; quiz 653. 2. Siegel R, Naishadham D, Jemal A. CA Cancer J Clin, Cancer statistics, 2013.,, 2013, 63,, 11-30, 3. Williams DE, Pairolero PC, Davis CS, Bernatz PE, Payne WS, Taylor WF, Uhlenhopp MA, Fontana RS. J Thorac Cardiovasc Surg, Survival of patients surgically treated for stage I lung cancer.,, 1981, 82,, 70-76, 4. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. J Clin Oncol, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.,, 2010, 28,, 1721-1726, 5. Ludwig JA, Weinstein JN. Nat Rev Cancer, Biomarkers in cancer staging, prognosis and treatment selection.,, 2005, 5,, 845-856,
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|